Bleeding risk with apixaban and dabigatran similar to aspirin, suggests study Dr. Kamal Kant Kohli19 Feb 2025 8:00 AM ISTA systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs)...
Abelacimab reduces ischemic Stroke Risk in Atrial Fibrillation Patients with fewer bleeding events: NEJM Dr Riya Dave31 Jan 2025 8:00 AM ISTResearchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for stroke, administration of...
Rivaroxaban Enhances Walking Distance in Peripheral Artery Disease Patients When Combined with Aspirin: NEJM Medha Baranwal3 Sept 2024 9:00 AM ISTBrazil: A recent clinical trial has shown that adding rivaroxaban to a standard aspirin regimen significantly improves walking distance for patients...
Apixaban offers safety benefits over both rivaroxaban and warfarin in patients with cirrhosis and AF: Study Dr. Kamal Kant Kohli19 July 2024 9:00 AM ISTA nationwide cohort study found that among patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiating treatment with anticoagulant...
Diltiazem use tied to serious bleeding risk in atrial fibrillation patients on apixaban or rivaroxaban: JAMA Medha Baranwal26 April 2024 9:45 AM ISTUSA: A recent study published in the Journal of the American Medical Association (JAMA) has revealed an increased risk of serious bleeding compared...
Rivaroxaban Plus Aspirin Shows Favorable Benefit-Risk Profile in PAD Patients after revascularization, suggests study Dr Riya Dave20 April 2024 8:30 AM ISTThe VOYAGER PAD trial evaluated the efficacy and safety of rivaroxaban plus aspirin compared to aspirin alone in patients with symptomatic peripheral...
AstraZeneca bags CDSCO nod to import, market Andexanet Alfa in India Ruchika Sharma23 Jan 2024 4:45 PM ISTBangalore: AstraZeneca Pharma India Ltd., has announced that it has received approval from Central Drugs Standard Control Organisation (CDSCO) in...
AstraZeneca gets CDSCO Panel Nod To Import, Market Andexanet alfa powder for solution for infusion Dr. Divya Colin27 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Amiodarone use in AF patients increases bleeding risk in patients on apixaban or rivaroxaban Dr. Kamal Kant Kohli29 May 2023 9:45 AM ISTUSA: Using amiodarone in patients aged 65 years or older with atrial fibrillation during apixaban or rivaroxaban (anticoagulants) raises the risk for...
Rivaroxaban chemoprophylaxis following TKA and THA associated with increased risk of bleeding compared to aspirin and enoxaparin Dr Supreeth D R17 April 2023 11:30 AM ISTAn optimal venous thromboembolism prophylaxis agent should balance efficacy and safety. While rivaroxaban provides effective venous thromboembolism...
Apixaban safer than other options for long-term anticoagulation among the elderly with AF Aditi15 April 2023 9:30 AM ISTAccording to an Original Investigation on Cardiology published in JAMA Network Open entitled, "Comparative Effectiveness and Safety of Oral...
DOACs better alternative than LMWH for cancer-associated thrombosis Dr. Kamal Kant Kohli28 Dec 2022 11:00 AM ISTResearchers have found in a new study that DOACs is a better alternative than LMWH for cancer-associated thrombosis. The cost-effectiveness analysis...
